Aedifica SA

AED.BR Q2 2026

Reported: 2026-09-03

Shares fell 2.0% following the earnings release, reflecting investor caution despite accretive EPS and initial synergy progress; concerns center on subdued like-for-like rent growth in core markets and ongoing negative impacts from portfolio mix and FX.

Key takeaways

EPRA earnings per share rose 5% to EUR 2.71, reflecting immediate accretion from the Cofinimmo merger.
Rental income surged 62% overall, driven by portfolio combination; normalized EBIT margin stands at 85.5%.
Like-for-like rental growth was uneven: 1.7% portfolio-wide, with strong 5.1% growth in the Netherlands (partly due to a business model shift) and 5% in the UK, but weakness in Belgium, Italy (negative), Finland, France, and offices (–1.3%).
Integration costs totaled approximately EUR 5 million in H1, treated as nonrecurring, while expected run-rate synergies of EUR 16 million are on track for 2027.
FX negatively impacted like-for-like growth by 0.4%, adding to mixed operational momentum across key geographies.

View recap

Bunzl plc

BNZL.L Q2 2026

Reported: 2026-09-03

Bunzl shares declined 2.8% after the earnings release, reflecting investor caution despite modest top-line growth and margin expansion. The cautious tone on future pricing pressures and the tempered outlook for sustained margin gains weighed on sentiment.

Key takeaways

Group revenue grew 4.1% at constant currency, with underlying growth of 3.2%, supported by volume and selling price increases.
Operating margin improved by 30 basis points to 7.3%, aided by temporary inflation effects and annualized synergies from prior acquisitions.
Adjusted operating profit increased 8% to GBP 441 million, while adjusted EPS rose 11%, partly boosted by share buybacks.
North American Distribution led volume growth at 4.6%, but inflationary cost pressures persisted, particularly from plastics and fuel.
Management noted that inflation-driven margin expansion is largely temporary, with early signs of price reductions expected in Q3, prompting cautious outlook on sustained profitability gains.

View recap

Credo Technology Group Holding Ltd Ordinary Shares

CRDO Q1 2027

Reported: 2026-09-03

Shares fell 27% as investors reacted negatively to a cautious outlook and indications of deceleration in the optical segment, overshadowing strong sequential revenue growth and margin expansion.

Key takeaways

Revenue reached a record $479 million, up 10% sequentially and more than doubling year over year.
Non-GAAP gross margin improved to 68%, supporting non-GAAP net income of $236 million, a 140% increase year over year.
Optical business showed progress with early silicon photonics PIC revenue and record DSP revenue but faces a transition to next-generation 1.6T solutions, introducing execution risk.
Management highlighted ongoing engagement with hyperscalers and neo cloud customers but noted the complexity and heterogeneity of future AI infrastructure could slow near-term adoption.
Despite strong product innovation, the market appears cautious on guidance and the pace of optical ramps, contributing to the sharp stock decline post-earnings.

View recap

Dell Technologies Inc.

DELL Q2 2027

Reported: 2026-09-03

Dell’s shares rose 7.9% following a clear beat on AI and traditional server demand, with record bookings and broad-based revenue growth that outweighed any lingering supply constraints or mixed segment dynamics.

Key takeaways

Revenue surged 58% year-over-year to $47 billion, driven by record AI and traditional server sales.
AI orders hit a new high at $60.9 billion in the quarter, contributing to a $95 billion AI backlog.
Traditional server revenue increased 122%, fueled by strong refresh cycles and expanded use cases tied to AI workloads.
Operating income for ISG reached $4.8 billion with a 15% margin, reflecting operating leverage amid rising demand.
Storage showed renewed growth and Client Solutions Group experienced its fastest revenue growth rate in five years.

View recap

GitLab Inc. Class A Common Stock

GTLB Q2 2027

Reported: 2026-09-03

GitLab’s shares rose 6.6% following an earnings report that demonstrated significant growth in bookings, net ARR, and early traction in a new consumption-based product, signaling acceleration and stronger monetization execution.

Key takeaways

Revenue increased 21% year-over-year to $286.3 million; non-GAAP operating income was $42.6 million, yielding a 15% operating margin.
Net ARR grew over 40% year-over-year, driven by a record gross bookings quarter and a 100% increase in first orders.
Sales capacity expanded by approximately 30% year-over-year, with a 10% increase in productivity per sales representative, alongside improved attrition.
Flex, the new consumption-based offering, generated over $20 million in customer commitments from more than 130 clients in six weeks, contributing to a paid consumption run rate rising from $15 million to over $40 million.
GitLab projects exiting the fiscal year with a diversified revenue base, combining seat subscriptions with a scaling consumption model.

View recap

MongoDB, Inc.

MDB Q2 2027

Reported: 2026-09-03

MongoDB’s shares dropped 17.2% following a cautious outlook and signs of deceleration in the pace of Atlas consumption growth, which overshadowed an otherwise solid revenue increase and customer additions.

Key takeaways

Total revenue grew 30% year-over-year to $772 million, driven by Atlas (29% growth) and EA plus other (36% growth).
Non-GAAP operating margin stood at 24%, supported by revenue growth but potentially facing future pressure.
Added a record 2,900 net new customers, bringing the total to 70,600, with notable growth in AI-native companies and new product adoption like Atlas Vector Search and Voyage Embeddings.
Management emphasized early momentum in AI workloads but did not provide clear visibility or confidence on the trajectory of Atlas consumption growth, contributing to investor wariness.
Despite highlighting strategic partnerships and product integration within the AI ecosystem, the cautious outlook on growth metrics and profitability outlook resulted in a significant negative market reaction.

View recap

Medtronic plc

MDT Q1 2027

Reported: 2026-09-03

Shares rose modestly by 1.7% following a solid quarter marked by strong revenue growth and continued share gains across key segments, though the market’s tepid response suggests investors remain cautious about near-term outlook or incremental upside.

Key takeaways

Revenue reached $9.8 billion with adjusted EPS of $1.45, both described as well ahead of expectations by management.
Organic revenue grew 13.7%, driven by Cardiac Rhythm Management (CRM) (+15%), Cranial & Spinal Technologies (CST) (+13%), and Surgical (+9%).
Cardiac Ablation Solutions delivered an 88% global growth, surpassing $2 billion in trailing 12-month revenue and expanding U.S. share by 9 points.
Recent acquisitions contributed positively to reported growth and portfolio strength.
Management emphasized durable, multi-platform growth and innovation pipelines, but the sub-3% stock rise suggests investors are withholding enthusiasm pending further clarity on outlook or execution risks.

View recap

NIO Inc.

NIO Q2 2026

Reported: 2026-09-03

Shares dropped 8.7% as investors reacted negatively to cautious delivery guidance indicating deceleration in sales growth and margin pressure from rising raw material and chip costs.

Key takeaways

Q2 deliveries totaled 107,658 vehicles, representing 49.4% year-over-year growth, but Q3 guidance narrowed to 108,000-111,000 units, signaling a moderation in growth.
Gross margin stood at 18.4%, supported by higher-margin products and cost optimization, yet raw material and chip cost pressures constrained expansion.
The company maintained non-GAAP operating profit and positive free cash flow, increasing cash reserves to RMB 56.7 billion.
Flagship models ES8 and ES9 led the premium segment with strong user adoption, but competitive pressures and margin compression warrant caution.
Continued investment in smart driving technology and infrastructure expansion signals long-term strategic focus but adds near-term execution risks.

View recap

Palo Alto Networks, Inc.

PANW Q4 2026

Reported: 2026-09-03

Shares of Palo Alto Networks dropped 14% following the earnings release as investor disappointment centered on a cautious outlook and deceleration signals despite strong headline bookings and ARR growth.

Key takeaways

Record RPO hit $21.2 billion, a 34% increase year-over-year, with GSARR up 63% to $9.1 billion, highlighting solid demand for next-generation security ARR.
Net new NGS ARR addition approached $1 billion in Q4, reflecting continued momentum in core platform adoption.
Platformization gains accelerated, with 22 new platformizations in the quarter (twice prior volume), and net revenue retention for platformized accounts surpassed 120%.
CEO commentary emphasized AI-driven transformation and broad adoption but introduced caution around evolving enterprise AI risks and integration complexity.
No explicit guidance details were provided in the transcript; however, the steep stock decline suggests the market parsed a cautious or less confident outlook relative to expectations.

View recap

Rezolve AI Limited Ordinary Shares

RZLV Q2 2026

Reported: 2026-09-03

Rezolve AI’s stock dropped 19.4% after the earnings release, reflecting investor disappointment with the cautious outlook and lack of clear near-term revenue visibility despite strong headline growth.

Key takeaways

Reported revenue surged to $130.8 million in H1 2026, up nearly 21x from $6.3 million in H1 2025, driven by rapid customer base expansion to over 1,640 from 950 at year-end.
The company highlighted significant strategic partnerships with Microsoft, Google, Tata Consultancy Services, and Tech Mahindra that provide scalable routes to market and enterprise deployments.
Google selected Rezolve’s proprietary distributed database for deployment within Google Cloud infrastructure, validating the technology and opening a long-term licensing opportunity.
Notwithstanding promising technology validation and partnership announcements, management emphasized execution priorities and hinted at gradual scaling rather than immediate profitability or clear near-term margin improvements.
No explicit guidance update or materially accelerated revenue forecast was provided, leaving investors cautious on the timing and magnitude of conversion from strategic partnerships and infrastructure licensing into cash flow.

View recap

Sibanye Stillwater Limited

SBSW Q2 2026

Reported: 2026-09-03

The stock rose 6.0% following the earnings release, reflecting investor approval of the company’s operational execution and strong cash generation amid a volatile commodity price environment.

Key takeaways

EBITDA more than doubled compared to the prior year period, excluding prior-year Section 45X benefits, indicating substantial underlying earnings growth.
Record net operating cash flow was achieved, underscoring effective cash conversion and margin control.
Strong safety performance was highlighted, although unfortunately fatalities still occurred, signaling room for improvement.
EBITDA and all-in sustaining cost margins remained solid, supporting the company’s competitive positioning.
Management emphasized progress against their strategic priorities of operational excellence, capital allocation, and growth from existing assets rather than external M&A.

View recap

Swiss Life Holding AG

SLHN.SW Q2 2026

Reported: 2026-09-03

Swiss Life’s shares declined modestly by 0.6% following the half-year results, reflecting cautious investor sentiment despite stable operational performance and moderate profit growth. The subdued market reaction likely stems from mixed segment results and cautious outlook signals embedded in efficiency-driven cost cuts and relatively flat premium growth in key markets.

Key takeaways

Profit from operations rose 8% (local currency) to CHF 967 million; net profit increased 8% to CHF 649 million despite a higher tax burden.
Fee result grew 11% to CHF 430 million, supported by gains from asset management, IFAs, and unit-linked business, including CHF 29 million from divesting the international network.
Gross written premiums, fees, and deposits increased 3% to CHF 12.3 billion, driven mainly by a 7% premium increase in Switzerland; however, premiums in France were flat amid a declining health and protection segment.
Net investment income on the insurance portfolio rose significantly from CHF 1.6 billion to CHF 2.4 billion, boosted by equities, infrastructure, and FX hedging effects.
Efficiency initiatives include a planned workforce reduction of 600 positions by 2028, aiming for CHF 150 million in annual cost savings starting 2029, signaling ongoing cost pressure and cautious margin management.

View recap

Zepp Health Corporation

ZEPP Q2 2026

Reported: 2026-09-03

Zepp Health’s shares rose modestly by 0.8% following Q1 2026 earnings, reflecting a generally mixed reception to solid revenue growth and margin expansion tempered by cautiousness around scale and broader market dynamics.

Key takeaways

Amazfit branded revenue increased 33.8% year-over-year in Q1, driven by successful launches of premium models like the ActiveMax Active 3 and T-Rex Ultra 2.
Average selling price rose more than 20% year-over-year, supported by a higher mix of premium products, notably with nearly 50% of T-Rex family units sold in March-April coming from higher-priced models.
Gross margin expanded despite inflationary pressures in memory and storage components, reflecting disciplined cost management and a premiumized product mix.
The company enhanced its hybrid training ecosystem through a three-year exclusive partnership with HYROX, aimed at strengthening brand positioning in a nascent training category.
Management emphasized strategic progress rather than a breakthrough quarter, indicating ongoing structural changes to improve pricing power and market differentiation.

View recap

Earnings Recaps

Aedifica SA

Bunzl plc

Credo Technology Group Holding Ltd Ordinary Shares

Dell Technologies Inc.

GitLab Inc. Class A Common Stock

MongoDB, Inc.

Medtronic plc

NIO Inc.

Palo Alto Networks, Inc.

Rezolve AI Limited Ordinary Shares

Sibanye Stillwater Limited

Swiss Life Holding AG

Zepp Health Corporation

Community

Earnings Recaps

Aedifica SA

Bunzl plc

Credo Technology Group Holding Ltd Ordinary Shares

Dell Technologies Inc.

GitLab Inc. Class A Common Stock

MongoDB, Inc.

Medtronic plc

NIO Inc.

Palo Alto Networks, Inc.

Rezolve AI Limited Ordinary Shares

Sibanye Stillwater Limited

Swiss Life Holding AG

Zepp Health Corporation

Community

Trending This Week

Notifications